Is this Alzheimer's drug a breakthrough for millions? Company unveils mixed results

https://ift.tt/1roPe8M

Biogen will seek FDA approval for an Alzheimer's drug with mixed results. Can this experimental medication slow the memory-robbing disease?

      


from USATODAY - News Top Stories Is this Alzheimer's drug a breakthrough for millions? Company unveils mixed results
Ken Alltucker, USA TODAY

Biogen will seek FDA approval for an Alzheimer's drug with mixed results. Can this experimental medication slow the memory-robbing disease?

      

December 05, 2019 at 10:09PM
https://ift.tt/2UWK6IU
https://ift.tt/38bb3ic

Popular Posts